Neurocrine UK Limited

Quick facts

Marketed products

• Cortef · Other

Phase 3 pipeline

• Infacort® · Endocrinology
  Infacort is a modified-release hydrocortisone formulation designed to mimic the natural circadian rhythm of cortisol secretion in patients with adrenal insufficiency.
• standard glucocorticoid therapy · Immunology
  Glucocorticoids reduce inflammation and suppress the immune system by binding to glucocorticoid receptors.

Phase 2 pipeline

• Hydrocortisone Modified Release Capsules · Oncology
  Glucocorticoid receptor agonist

Phase 1 pipeline

• Chronocort: fasted
• Chronocort: fed
• DITEST
• Immediate release hydrocortisone: fasted

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Neurocrine UK Limited portfolio CI brief
• Neurocrine UK Limited pipeline updates RSS